Batterioterapia fecale (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Batterioterapia fecale" in Italian language version.

refsWebsite

Global rank Italian rank

45nih.gov

4^th place

9^th place

37doi.org

2^nd place

7^th place

32oadoi.org

799^th place

22^nd place

9web.archive.org

1^st place

5archive.org

6^th place

8^th place

2books.google.com

3^rd place

14^th place

2cbc.ca

115^th place

387^th place

1nejm.org

2,374^th place

1,283^rd place

1cdc.gov

218^th place

774^th place

1newscientist.com

774^th place

1,120^th place

1uol.com.br

74^th place

428^th place

1medicitalia.it

low place

3,296^th place

archive.org

AA. MacConnachie, R. Fox; DR. Kennedy; RA. Seaton, Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series., in QJM, vol. 102, n. 11, novembre 2009, pp. 781-4, DOI:10.1093/qjmed/hcp118, PMID 19726581.
TJ. Borody, EF. Warren; S. Leis; R. Surace; O. Ashman, Treatment of ulcerative colitis using fecal bacteriotherapy., in J Clin Gastroenterol, vol. 37, n. 1, luglio 2003, pp. 42-7, PMID 12811208.
Lewin, Ralph A., More on Merde, in Perspectives in Biology and Medicine, vol. 44, n. 4, 2001, pp. 594–607, DOI:10.1353/pbm.2001.0067, PMID 11600805.
FC. Tenover, T. Akerlund; DN. Gerding; RV. Goering; T. Boström; AM. Jonsson; E. Wong; AT. Wortman; DH. Persing, Comparison of strain typing results for Clostridium difficile isolates from North America., in J Clin Microbiol, vol. 49, n. 5, maggio 2011, pp. 1831-7, DOI:10.1128/JCM.02446-10, PMID 21389155.
LP. Smits, KE. Bouter; WM. de Vos; TJ. Borody; M. Nieuwdorp, Therapeutic potential of fecal microbiota transplantation., in Gastroenterology, vol. 145, n. 5, novembre 2013, pp. 946-53, DOI:10.1053/j.gastro.2013.08.058, PMID 24018052.

books.google.com

Thomas M. Smith e Robert L. Smith, Elementi di ecologia, Pearson Paravia Bruno Mondad, 2007, pp. 134–, ISBN 978-88-7192-350-5. URL consultato il 29 agosto 2011.
Joan R. Callahan, Emerging Biological Threats: A Reference Guide, ABC-CLIO, 23 dicembre 2009, pp. 74–, ISBN 978-0-313-37209-4.

cbc.ca

News, C.B.C., Don't poo-poo technique: Fecal transplant can cure superbug, doctors say, in CBC News, 2007. URL consultato il 27 agosto 2011.
cbc.radio-canada.ca, Don't poo-poo technique: Fecal transplant can cure superbug, doctors say, 2007. URL consultato il 26 agosto 2011.

cdc.gov

Centers for Disease Control e Prevention, Clostridium difficile Infection (CDI, C. diff) - Healthcare-associated Infections (HAIs), 2007.

doi.org

dx.doi.org

G. Russell, J. Kaplan; M. Ferraro; IC. Michelow, Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol., in Pediatrics, vol. 126, n. 1, luglio 2010, pp. e239-42, DOI:10.1542/peds.2009-3363, PMID 20547640.
AA. MacConnachie, R. Fox; DR. Kennedy; RA. Seaton, Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series., in QJM, vol. 102, n. 11, novembre 2009, pp. 781-4, DOI:10.1093/qjmed/hcp118, PMID 19726581.
W. Glauser, Risk and rewards of fecal transplants., in CMAJ, vol. 183, n. 5, marzo 2011, pp. 541-2, DOI:10.1503/cmaj.109-3806, PMID 21398226.
Lewin, Ralph A., More on Merde, in Perspectives in Biology and Medicine, vol. 44, n. 4, 2001, pp. 594–607, DOI:10.1353/pbm.2001.0067, PMID 11600805.
J. Aas, CE. Gessert; JS. Bakken, Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube., in Clin Infect Dis, vol. 36, n. 5, marzo 2003, pp. 580-5, DOI:10.1086/367657, PMID 12594638.
PJ. Turnbaugh, VK. Ridaura; JJ. Faith; FE. Rey; R. Knight; JI. Gordon, The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice., in Sci Transl Med, vol. 1, n. 6, novembre 2009, pp. 6ra14, DOI:10.1126/scitranslmed.3000322, PMID 20368178.
S. Prakash, L. Rodes; M. Coussa-Charley; C. Tomaro-Duchesneau, Gut microbiota: next frontier in understanding human health and development of biotherapeutics., in Biologics, vol. 5, 2011, pp. 71-86, DOI:10.2147/BTT.S19099, PMID 21847343.
PM. Smith, WS. Garrett, The gut microbiota and mucosal T cells., in Front Microbiol, vol. 2, 2011, p. 111, DOI:10.3389/fmicb.2011.00111, PMID 21833339.
H. Tilg, A. Kaser, Gut microbiome, obesity, and metabolic dysfunction., in J Clin Invest, vol. 121, n. 6, giugno 2011, pp. 2126-32, DOI:10.1172/JCI58109, PMID 21633181.
J. Matricon, N. Barnich; D. Ardid, Immunopathogenesis of inflammatory bowel disease., in Self Nonself, vol. 1, n. 4, ottobre 2010, pp. 299-309, DOI:10.4161/self.1.4.13560, PMID 21487504.
DA. Relman, Microbial genomics and infectious diseases., in N Engl J Med, vol. 365, n. 4, luglio 2011, pp. 347-57, DOI:10.1056/NEJMra1003071, PMID 21793746.
JG. Bartlett, TW. Chang; M. Gurwith; SL. Gorbach; AB. Onderdonk, Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia., in N Engl J Med, vol. 298, n. 10, marzo 1978, pp. 531-4, DOI:10.1056/NEJM197803092981003, PMID 625309.
J. Hemminger, JM. Balada-Llasat; M. Raczkowski; M. Buckosh; P. Pancholi, Two case reports of Clostridium difficile bacteremia, one with the epidemic NAP-1 strain., in Infection, aprile 2011, DOI:10.1007/s15010-011-0115-7, PMID 21509425.
J. Cloud, L. Noddin; A. Pressman; M. Hu; C. Kelly, Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting., in Clin Gastroenterol Hepatol, vol. 7, n. 8, agosto 2009, pp. 868-873.e2, DOI:10.1016/j.cgh.2009.05.018, PMID 19465153.
J. Kok, Q. Wang; LC. Thomas; GL. Gilbert, Presumptive identification of Clostridium difficile 027/NAP1/BI on Cepheid Xpert(R) - interpret with caution., in J Clin Microbiol, agosto 2011, DOI:10.1128/JCM.00752-11, PMID 21849697.
FC. Tenover, T. Akerlund; DN. Gerding; RV. Goering; T. Boström; AM. Jonsson; E. Wong; AT. Wortman; DH. Persing, Comparison of strain typing results for Clostridium difficile isolates from North America., in J Clin Microbiol, vol. 49, n. 5, maggio 2011, pp. 1831-7, DOI:10.1128/JCM.02446-10, PMID 21389155.
JG. Bartlett, Clostridium difficile: progress and challenges., in Ann N Y Acad Sci, vol. 1213, dicembre 2010, pp. 62-9, DOI:10.1111/j.1749-6632.2010.05863.x, PMID 21175676.
Pant C, Sferra TJ, Deshpande A, Minocha A, Clinical approach to severe Clostridium difficile infection: update for the hospital practitioner, in Eur. J. Intern. Med., vol. 22, n. 6, dicembre 2011, pp. 561–8, DOI:10.1016/j.ejim.2011.04.009, PMID 22075280.
T. Chopra, GJ. Alangaden; P. Chandrasekar, Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients., in Expert Rev Anti Infect Ther, vol. 8, n. 10, ottobre 2010, pp. 1113-9, DOI:10.1586/eri.10.95, PMID 20954878.
MG. Hautmann, M. Hipp; O. Kölbl, Clostridium difficile-associated diarrhea in radiooncology: an underestimated problem for the feasibility of the radiooncological treatment?, in Radiat Oncol, vol. 6, 2011, p. 89, DOI:10.1186/1748-717X-6-89, PMID 21806799.
R. Voelker, Increased Clostridium difficile virulence demands new treatment approach., in JAMA, vol. 303, n. 20, maggio 2010, pp. 2017-9, DOI:10.1001/jama.2010.647, PMID 20501917.
C. Denève, C. Janoir; I. Poilane; C. Fantinato; A. Collignon, New trends in Clostridium difficile virulence and pathogenesis., in Int J Antimicrob Agents, 33 Suppl 1, marzo 2009, pp. S24-8, DOI:10.1016/S0924-8579(09)70012-3, PMID 19303565.
A. Khoruts, J. Dicksved; JK. Jansson; MJ. Sadowsky, Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea., in J Clin Gastroenterol, vol. 44, n. 5, pp. 354-60, DOI:10.1097/MCG.0b013e3181c87e02, PMID 20048681.
MS. Silverman, I. Davis; DR. Pillai, Success of self-administered home fecal transplantation for chronic Clostridium difficile infection., in Clin Gastroenterol Hepatol, vol. 8, n. 5, maggio 2010, pp. 471-3, DOI:10.1016/j.cgh.2010.01.007, PMID 20117243.
Kahn SA, Gorawara-Bhat R, Rubin DT, Fecal bacteriotherapy for ulcerative colitis: Patients are ready, are we?, in Inflamm. Bowel Dis., maggio 2011, DOI:10.1002/ibd.21775, PMC 3183116, PMID 21618362.
S. Kunde, A. Pham; S. Bonczyk; C. Teri; M. Duba; H. Conrad; D. Cloney; S. Kugathasan, Safety, Tolerability, and Clinical Response after Fecal Transplantation in Children and Young Adults with Ulcerative Colitis., in J Pediatr Gastroenterol Nutr, marzo 2013, DOI:10.1097/MPG.0b013e318292fa0d, PMID 23542823.
LP. Smits, KE. Bouter; WM. de Vos; TJ. Borody; M. Nieuwdorp, Therapeutic potential of fecal microbiota transplantation., in Gastroenterology, vol. 145, n. 5, novembre 2013, pp. 946-53, DOI:10.1053/j.gastro.2013.08.058, PMID 24018052.
MQ. Xu, HL. Cao; WQ. Wang; S. Wang; XC. Cao; F. Yan; BM. Wang, Fecal microbiota transplantation broadening its application beyond intestinal disorders., in World J Gastroenterol, vol. 21, n. 1, gennaio 2015, pp. 102-11, DOI:10.3748/wjg.v21.i1.102, PMID 25574083.
JS. Bakken, Fecal bacteriotherapy for recurrent Clostridium difficile infection., in Anaerobe, vol. 15, n. 6, dicembre 2009, pp. 285-9, DOI:10.1016/j.anaerobe.2009.09.007, PMID 19778623.
Kelly CR, de Leon L, Jasutkar N, Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection in 26 Patients: Methodology and Results, in J Clin Gastroenterol, dicembre 2011, DOI:10.1097/MCG.0b013e318234570b, PMID 22157239.
E. Mattila, R. Uusitalo-Seppälä; M. Wuorela; L. Lehtola; H. Nurmi; M. Ristikankare; V. Moilanen; K. Salminen; M. Seppälä; PS. Mattila; VJ. Anttila, Fecal Transplantation, Through Colonoscopy, Is Effective Therapy for Recurrent Clostridium difficile Infection., in Gastroenterology, dicembre 2011, DOI:10.1053/j.gastro.2011.11.037, PMID 22155369.
Gough E, Shaikh H, Manges AR, Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection, in Clin. Infect. Dis., vol. 53, n. 10, novembre 2011, pp. 994–1002, DOI:10.1093/cid/cir632, PMID 22002980.
Cammarota G, Masucci L, Ianiro G, Bibbò S, Dinoi G, Costamagna G, Sanguinetti M, Gasbarrini A, Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection, in Aliment. Pharmacol. Ther., vol. 41, n. 9, 2015, pp. 835–43, DOI:10.1111/apt.13144, PMID 25728808.
MH. Floch, WA. Walker; S. Guandalini; P. Hibberd; S. Gorbach; C. Surawicz; ME. Sanders; G. Garcia-Tsao; EM. Quigley; E. Isolauri; RN. Fedorak, Recommendations for probiotic use--2008., in J Clin Gastroenterol, 42 Suppl 2, luglio 2008, pp. S104-8, DOI:10.1097/MCG.0b013e31816b903f, PMID 18542033.
Floch MH, Walker WA, Madsen K, et al., Recommendations for probiotic use-2011 update, in J. Clin. Gastroenterol., 45 Suppl, novembre 2011, pp. S168–71, DOI:10.1097/MCG.0b013e318230928b, PMID 21992958.
Z. Kassam, CH. Lee; Y. Yuan; RH. Hunt, Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis., in Am J Gastroenterol, vol. 108, n. 4, aprile 2013, pp. 500-8, DOI:10.1038/ajg.2013.59, PMID 23511459.
GY. Im, RJ. Modayil; CT. Lin; SJ. Geier; DS. Katz; M. Feuerman; JH. Grendell, The Appendix May Protect Against Clostridium difficile Recurrence., in Clin Gastroenterol Hepatol, vol. 9, n. 12, dicembre 2011, pp. 1072-7, DOI:10.1016/j.cgh.2011.06.006, PMID 21699818.

medicitalia.it

Il trapianto di feci cura la colite da C. difficile

nejm.org

MMS: Error Archiviato il 20 gennaio 2013 in Internet Archive.

newscientist.com

Ananthaswamy, Anil, Faecal transplant eases symptoms of Parkinson's, in New Scientist Health, 2011. URL consultato il 25 agosto 2011.

nih.gov

ncbi.nlm.nih.gov

G. Russell, J. Kaplan; M. Ferraro; IC. Michelow, Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol., in Pediatrics, vol. 126, n. 1, luglio 2010, pp. e239-42, DOI:10.1542/peds.2009-3363, PMID 20547640.
AA. MacConnachie, R. Fox; DR. Kennedy; RA. Seaton, Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series., in QJM, vol. 102, n. 11, novembre 2009, pp. 781-4, DOI:10.1093/qjmed/hcp118, PMID 19726581.
TJ. Borody, EF. Warren; S. Leis; R. Surace; O. Ashman, Treatment of ulcerative colitis using fecal bacteriotherapy., in J Clin Gastroenterol, vol. 37, n. 1, luglio 2003, pp. 42-7, PMID 12811208.
W. Glauser, Risk and rewards of fecal transplants., in CMAJ, vol. 183, n. 5, marzo 2011, pp. 541-2, DOI:10.1503/cmaj.109-3806, PMID 21398226.
Lewin, Ralph A., More on Merde, in Perspectives in Biology and Medicine, vol. 44, n. 4, 2001, pp. 594–607, DOI:10.1353/pbm.2001.0067, PMID 11600805.
TJ. Borody, EF. Warren; SM. Leis; R. Surace; O. Ashman; S. Siarakas, Bacteriotherapy using fecal flora: toying with human motions., in J Clin Gastroenterol, vol. 38, n. 6, luglio 2004, pp. 475-83, PMID 15220681.
J. Aas, CE. Gessert; JS. Bakken, Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube., in Clin Infect Dis, vol. 36, n. 5, marzo 2003, pp. 580-5, DOI:10.1086/367657, PMID 12594638.
E. Nurmi, M. Rantala, New aspects of Salmonella infection in broiler production., in Nature, vol. 241, n. 5386, gennaio 1973, pp. 210-1, PMID 4700893.
PJ. Turnbaugh, VK. Ridaura; JJ. Faith; FE. Rey; R. Knight; JI. Gordon, The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice., in Sci Transl Med, vol. 1, n. 6, novembre 2009, pp. 6ra14, DOI:10.1126/scitranslmed.3000322, PMID 20368178.
S. Prakash, L. Rodes; M. Coussa-Charley; C. Tomaro-Duchesneau, Gut microbiota: next frontier in understanding human health and development of biotherapeutics., in Biologics, vol. 5, 2011, pp. 71-86, DOI:10.2147/BTT.S19099, PMID 21847343.
PM. Smith, WS. Garrett, The gut microbiota and mucosal T cells., in Front Microbiol, vol. 2, 2011, p. 111, DOI:10.3389/fmicb.2011.00111, PMID 21833339.
H. Tilg, A. Kaser, Gut microbiome, obesity, and metabolic dysfunction., in J Clin Invest, vol. 121, n. 6, giugno 2011, pp. 2126-32, DOI:10.1172/JCI58109, PMID 21633181.
J. Matricon, N. Barnich; D. Ardid, Immunopathogenesis of inflammatory bowel disease., in Self Nonself, vol. 1, n. 4, ottobre 2010, pp. 299-309, DOI:10.4161/self.1.4.13560, PMID 21487504.
DA. Relman, Microbial genomics and infectious diseases., in N Engl J Med, vol. 365, n. 4, luglio 2011, pp. 347-57, DOI:10.1056/NEJMra1003071, PMID 21793746.
O. Soave, CD. Brand, Coprophagy in animals: a review., in Cornell Vet, vol. 81, n. 4, ottobre 1991, pp. 357-64, PMID 1954740.
JG. Bartlett, TW. Chang; M. Gurwith; SL. Gorbach; AB. Onderdonk, Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia., in N Engl J Med, vol. 298, n. 10, marzo 1978, pp. 531-4, DOI:10.1056/NEJM197803092981003, PMID 625309.
LC. McDonald, M. Owings; DB. Jernigan, Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003., in Emerg Infect Dis, vol. 12, n. 3, marzo 2006, pp. 409-15, PMID 16704777.
J. Hemminger, JM. Balada-Llasat; M. Raczkowski; M. Buckosh; P. Pancholi, Two case reports of Clostridium difficile bacteremia, one with the epidemic NAP-1 strain., in Infection, aprile 2011, DOI:10.1007/s15010-011-0115-7, PMID 21509425.
JG. Bartlett, New antimicrobial agents for patients with Clostridium difficile infections., in Curr Infect Dis Rep, vol. 11, n. 1, gennaio 2009, pp. 21-8, PMID 19094821.
J. Cloud, L. Noddin; A. Pressman; M. Hu; C. Kelly, Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting., in Clin Gastroenterol Hepatol, vol. 7, n. 8, agosto 2009, pp. 868-873.e2, DOI:10.1016/j.cgh.2009.05.018, PMID 19465153.
J. Kok, Q. Wang; LC. Thomas; GL. Gilbert, Presumptive identification of Clostridium difficile 027/NAP1/BI on Cepheid Xpert(R) - interpret with caution., in J Clin Microbiol, agosto 2011, DOI:10.1128/JCM.00752-11, PMID 21849697.
FC. Tenover, T. Akerlund; DN. Gerding; RV. Goering; T. Boström; AM. Jonsson; E. Wong; AT. Wortman; DH. Persing, Comparison of strain typing results for Clostridium difficile isolates from North America., in J Clin Microbiol, vol. 49, n. 5, maggio 2011, pp. 1831-7, DOI:10.1128/JCM.02446-10, PMID 21389155.
JG. Bartlett, Clostridium difficile: progress and challenges., in Ann N Y Acad Sci, vol. 1213, dicembre 2010, pp. 62-9, DOI:10.1111/j.1749-6632.2010.05863.x, PMID 21175676.
Pant C, Sferra TJ, Deshpande A, Minocha A, Clinical approach to severe Clostridium difficile infection: update for the hospital practitioner, in Eur. J. Intern. Med., vol. 22, n. 6, dicembre 2011, pp. 561–8, DOI:10.1016/j.ejim.2011.04.009, PMID 22075280.
T. Chopra, GJ. Alangaden; P. Chandrasekar, Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients., in Expert Rev Anti Infect Ther, vol. 8, n. 10, ottobre 2010, pp. 1113-9, DOI:10.1586/eri.10.95, PMID 20954878.
MG. Hautmann, M. Hipp; O. Kölbl, Clostridium difficile-associated diarrhea in radiooncology: an underestimated problem for the feasibility of the radiooncological treatment?, in Radiat Oncol, vol. 6, 2011, p. 89, DOI:10.1186/1748-717X-6-89, PMID 21806799.
L. Cuzzolin, D. Zambreri; M. Donini; C. Griso; G. Benoni, Influence of radiotherapy on intestinal microflora in cancer patients., in J Chemother, vol. 4, n. 3, giugno 1992, pp. 176-9, PMID 1517812.
R. Voelker, Increased Clostridium difficile virulence demands new treatment approach., in JAMA, vol. 303, n. 20, maggio 2010, pp. 2017-9, DOI:10.1001/jama.2010.647, PMID 20501917.
C. Denève, C. Janoir; I. Poilane; C. Fantinato; A. Collignon, New trends in Clostridium difficile virulence and pathogenesis., in Int J Antimicrob Agents, 33 Suppl 1, marzo 2009, pp. S24-8, DOI:10.1016/S0924-8579(09)70012-3, PMID 19303565.
A. Khoruts, J. Dicksved; JK. Jansson; MJ. Sadowsky, Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea., in J Clin Gastroenterol, vol. 44, n. 5, pp. 354-60, DOI:10.1097/MCG.0b013e3181c87e02, PMID 20048681.
M.D. Thomas J. Borody e M.A. Ori Ashman, Treatment of Ulcerative Colitis Using Fecal Bacteriotherapy (PDF), in J Clin Gastroenterol, vol. 37, n. 1, 2003, pp. 42–47, PMID 1281120. URL consultato il 27 agosto 2011 (archiviato dall'url originale il 25 agosto 2011).
MS. Silverman, I. Davis; DR. Pillai, Success of self-administered home fecal transplantation for chronic Clostridium difficile infection., in Clin Gastroenterol Hepatol, vol. 8, n. 5, maggio 2010, pp. 471-3, DOI:10.1016/j.cgh.2010.01.007, PMID 20117243.
Kahn SA, Gorawara-Bhat R, Rubin DT, Fecal bacteriotherapy for ulcerative colitis: Patients are ready, are we?, in Inflamm. Bowel Dis., maggio 2011, DOI:10.1002/ibd.21775, PMC 3183116, PMID 21618362.
S. Kunde, A. Pham; S. Bonczyk; C. Teri; M. Duba; H. Conrad; D. Cloney; S. Kugathasan, Safety, Tolerability, and Clinical Response after Fecal Transplantation in Children and Young Adults with Ulcerative Colitis., in J Pediatr Gastroenterol Nutr, marzo 2013, DOI:10.1097/MPG.0b013e318292fa0d, PMID 23542823.
LP. Smits, KE. Bouter; WM. de Vos; TJ. Borody; M. Nieuwdorp, Therapeutic potential of fecal microbiota transplantation., in Gastroenterology, vol. 145, n. 5, novembre 2013, pp. 946-53, DOI:10.1053/j.gastro.2013.08.058, PMID 24018052.
MQ. Xu, HL. Cao; WQ. Wang; S. Wang; XC. Cao; F. Yan; BM. Wang, Fecal microbiota transplantation broadening its application beyond intestinal disorders., in World J Gastroenterol, vol. 21, n. 1, gennaio 2015, pp. 102-11, DOI:10.3748/wjg.v21.i1.102, PMID 25574083.
JS. Bakken, Fecal bacteriotherapy for recurrent Clostridium difficile infection., in Anaerobe, vol. 15, n. 6, dicembre 2009, pp. 285-9, DOI:10.1016/j.anaerobe.2009.09.007, PMID 19778623.
Kelly CR, de Leon L, Jasutkar N, Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection in 26 Patients: Methodology and Results, in J Clin Gastroenterol, dicembre 2011, DOI:10.1097/MCG.0b013e318234570b, PMID 22157239.
E. Mattila, R. Uusitalo-Seppälä; M. Wuorela; L. Lehtola; H. Nurmi; M. Ristikankare; V. Moilanen; K. Salminen; M. Seppälä; PS. Mattila; VJ. Anttila, Fecal Transplantation, Through Colonoscopy, Is Effective Therapy for Recurrent Clostridium difficile Infection., in Gastroenterology, dicembre 2011, DOI:10.1053/j.gastro.2011.11.037, PMID 22155369.
Gough E, Shaikh H, Manges AR, Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection, in Clin. Infect. Dis., vol. 53, n. 10, novembre 2011, pp. 994–1002, DOI:10.1093/cid/cir632, PMID 22002980.
Cammarota G, Masucci L, Ianiro G, Bibbò S, Dinoi G, Costamagna G, Sanguinetti M, Gasbarrini A, Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection, in Aliment. Pharmacol. Ther., vol. 41, n. 9, 2015, pp. 835–43, DOI:10.1111/apt.13144, PMID 25728808.
MH. Floch, WA. Walker; S. Guandalini; P. Hibberd; S. Gorbach; C. Surawicz; ME. Sanders; G. Garcia-Tsao; EM. Quigley; E. Isolauri; RN. Fedorak, Recommendations for probiotic use--2008., in J Clin Gastroenterol, 42 Suppl 2, luglio 2008, pp. S104-8, DOI:10.1097/MCG.0b013e31816b903f, PMID 18542033.
Floch MH, Walker WA, Madsen K, et al., Recommendations for probiotic use-2011 update, in J. Clin. Gastroenterol., 45 Suppl, novembre 2011, pp. S168–71, DOI:10.1097/MCG.0b013e318230928b, PMID 21992958.
Z. Kassam, CH. Lee; Y. Yuan; RH. Hunt, Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis., in Am J Gastroenterol, vol. 108, n. 4, aprile 2013, pp. 500-8, DOI:10.1038/ajg.2013.59, PMID 23511459.
GY. Im, RJ. Modayil; CT. Lin; SJ. Geier; DS. Katz; M. Feuerman; JH. Grendell, The Appendix May Protect Against Clostridium difficile Recurrence., in Clin Gastroenterol Hepatol, vol. 9, n. 12, dicembre 2011, pp. 1072-7, DOI:10.1016/j.cgh.2011.06.006, PMID 21699818.

oadoi.org

G. Russell, J. Kaplan; M. Ferraro; IC. Michelow, Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol., in Pediatrics, vol. 126, n. 1, luglio 2010, pp. e239-42, DOI:10.1542/peds.2009-3363, PMID 20547640.
W. Glauser, Risk and rewards of fecal transplants., in CMAJ, vol. 183, n. 5, marzo 2011, pp. 541-2, DOI:10.1503/cmaj.109-3806, PMID 21398226.
J. Aas, CE. Gessert; JS. Bakken, Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube., in Clin Infect Dis, vol. 36, n. 5, marzo 2003, pp. 580-5, DOI:10.1086/367657, PMID 12594638.
PJ. Turnbaugh, VK. Ridaura; JJ. Faith; FE. Rey; R. Knight; JI. Gordon, The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice., in Sci Transl Med, vol. 1, n. 6, novembre 2009, pp. 6ra14, DOI:10.1126/scitranslmed.3000322, PMID 20368178.
S. Prakash, L. Rodes; M. Coussa-Charley; C. Tomaro-Duchesneau, Gut microbiota: next frontier in understanding human health and development of biotherapeutics., in Biologics, vol. 5, 2011, pp. 71-86, DOI:10.2147/BTT.S19099, PMID 21847343.
PM. Smith, WS. Garrett, The gut microbiota and mucosal T cells., in Front Microbiol, vol. 2, 2011, p. 111, DOI:10.3389/fmicb.2011.00111, PMID 21833339.
H. Tilg, A. Kaser, Gut microbiome, obesity, and metabolic dysfunction., in J Clin Invest, vol. 121, n. 6, giugno 2011, pp. 2126-32, DOI:10.1172/JCI58109, PMID 21633181.
J. Matricon, N. Barnich; D. Ardid, Immunopathogenesis of inflammatory bowel disease., in Self Nonself, vol. 1, n. 4, ottobre 2010, pp. 299-309, DOI:10.4161/self.1.4.13560, PMID 21487504.
DA. Relman, Microbial genomics and infectious diseases., in N Engl J Med, vol. 365, n. 4, luglio 2011, pp. 347-57, DOI:10.1056/NEJMra1003071, PMID 21793746.
JG. Bartlett, TW. Chang; M. Gurwith; SL. Gorbach; AB. Onderdonk, Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia., in N Engl J Med, vol. 298, n. 10, marzo 1978, pp. 531-4, DOI:10.1056/NEJM197803092981003, PMID 625309.
J. Hemminger, JM. Balada-Llasat; M. Raczkowski; M. Buckosh; P. Pancholi, Two case reports of Clostridium difficile bacteremia, one with the epidemic NAP-1 strain., in Infection, aprile 2011, DOI:10.1007/s15010-011-0115-7, PMID 21509425.
J. Cloud, L. Noddin; A. Pressman; M. Hu; C. Kelly, Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting., in Clin Gastroenterol Hepatol, vol. 7, n. 8, agosto 2009, pp. 868-873.e2, DOI:10.1016/j.cgh.2009.05.018, PMID 19465153.
J. Kok, Q. Wang; LC. Thomas; GL. Gilbert, Presumptive identification of Clostridium difficile 027/NAP1/BI on Cepheid Xpert(R) - interpret with caution., in J Clin Microbiol, agosto 2011, DOI:10.1128/JCM.00752-11, PMID 21849697.
JG. Bartlett, Clostridium difficile: progress and challenges., in Ann N Y Acad Sci, vol. 1213, dicembre 2010, pp. 62-9, DOI:10.1111/j.1749-6632.2010.05863.x, PMID 21175676.
Pant C, Sferra TJ, Deshpande A, Minocha A, Clinical approach to severe Clostridium difficile infection: update for the hospital practitioner, in Eur. J. Intern. Med., vol. 22, n. 6, dicembre 2011, pp. 561–8, DOI:10.1016/j.ejim.2011.04.009, PMID 22075280.
T. Chopra, GJ. Alangaden; P. Chandrasekar, Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients., in Expert Rev Anti Infect Ther, vol. 8, n. 10, ottobre 2010, pp. 1113-9, DOI:10.1586/eri.10.95, PMID 20954878.
MG. Hautmann, M. Hipp; O. Kölbl, Clostridium difficile-associated diarrhea in radiooncology: an underestimated problem for the feasibility of the radiooncological treatment?, in Radiat Oncol, vol. 6, 2011, p. 89, DOI:10.1186/1748-717X-6-89, PMID 21806799.
R. Voelker, Increased Clostridium difficile virulence demands new treatment approach., in JAMA, vol. 303, n. 20, maggio 2010, pp. 2017-9, DOI:10.1001/jama.2010.647, PMID 20501917.
C. Denève, C. Janoir; I. Poilane; C. Fantinato; A. Collignon, New trends in Clostridium difficile virulence and pathogenesis., in Int J Antimicrob Agents, 33 Suppl 1, marzo 2009, pp. S24-8, DOI:10.1016/S0924-8579(09)70012-3, PMID 19303565.
A. Khoruts, J. Dicksved; JK. Jansson; MJ. Sadowsky, Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea., in J Clin Gastroenterol, vol. 44, n. 5, pp. 354-60, DOI:10.1097/MCG.0b013e3181c87e02, PMID 20048681.
MS. Silverman, I. Davis; DR. Pillai, Success of self-administered home fecal transplantation for chronic Clostridium difficile infection., in Clin Gastroenterol Hepatol, vol. 8, n. 5, maggio 2010, pp. 471-3, DOI:10.1016/j.cgh.2010.01.007, PMID 20117243.
S. Kunde, A. Pham; S. Bonczyk; C. Teri; M. Duba; H. Conrad; D. Cloney; S. Kugathasan, Safety, Tolerability, and Clinical Response after Fecal Transplantation in Children and Young Adults with Ulcerative Colitis., in J Pediatr Gastroenterol Nutr, marzo 2013, DOI:10.1097/MPG.0b013e318292fa0d, PMID 23542823.
MQ. Xu, HL. Cao; WQ. Wang; S. Wang; XC. Cao; F. Yan; BM. Wang, Fecal microbiota transplantation broadening its application beyond intestinal disorders., in World J Gastroenterol, vol. 21, n. 1, gennaio 2015, pp. 102-11, DOI:10.3748/wjg.v21.i1.102, PMID 25574083.
JS. Bakken, Fecal bacteriotherapy for recurrent Clostridium difficile infection., in Anaerobe, vol. 15, n. 6, dicembre 2009, pp. 285-9, DOI:10.1016/j.anaerobe.2009.09.007, PMID 19778623.
Kelly CR, de Leon L, Jasutkar N, Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection in 26 Patients: Methodology and Results, in J Clin Gastroenterol, dicembre 2011, DOI:10.1097/MCG.0b013e318234570b, PMID 22157239.
E. Mattila, R. Uusitalo-Seppälä; M. Wuorela; L. Lehtola; H. Nurmi; M. Ristikankare; V. Moilanen; K. Salminen; M. Seppälä; PS. Mattila; VJ. Anttila, Fecal Transplantation, Through Colonoscopy, Is Effective Therapy for Recurrent Clostridium difficile Infection., in Gastroenterology, dicembre 2011, DOI:10.1053/j.gastro.2011.11.037, PMID 22155369.
Gough E, Shaikh H, Manges AR, Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection, in Clin. Infect. Dis., vol. 53, n. 10, novembre 2011, pp. 994–1002, DOI:10.1093/cid/cir632, PMID 22002980.
Cammarota G, Masucci L, Ianiro G, Bibbò S, Dinoi G, Costamagna G, Sanguinetti M, Gasbarrini A, Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection, in Aliment. Pharmacol. Ther., vol. 41, n. 9, 2015, pp. 835–43, DOI:10.1111/apt.13144, PMID 25728808.
MH. Floch, WA. Walker; S. Guandalini; P. Hibberd; S. Gorbach; C. Surawicz; ME. Sanders; G. Garcia-Tsao; EM. Quigley; E. Isolauri; RN. Fedorak, Recommendations for probiotic use--2008., in J Clin Gastroenterol, 42 Suppl 2, luglio 2008, pp. S104-8, DOI:10.1097/MCG.0b013e31816b903f, PMID 18542033.
Floch MH, Walker WA, Madsen K, et al., Recommendations for probiotic use-2011 update, in J. Clin. Gastroenterol., 45 Suppl, novembre 2011, pp. S168–71, DOI:10.1097/MCG.0b013e318230928b, PMID 21992958.
Z. Kassam, CH. Lee; Y. Yuan; RH. Hunt, Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis., in Am J Gastroenterol, vol. 108, n. 4, aprile 2013, pp. 500-8, DOI:10.1038/ajg.2013.59, PMID 23511459.
GY. Im, RJ. Modayil; CT. Lin; SJ. Geier; DS. Katz; M. Feuerman; JH. Grendell, The Appendix May Protect Against Clostridium difficile Recurrence., in Clin Gastroenterol Hepatol, vol. 9, n. 12, dicembre 2011, pp. 1072-7, DOI:10.1016/j.cgh.2011.06.006, PMID 21699818.

uol.com.br

www1.folha.uol.com.br

Folha.com, Bactéria fecal de marido salva mulher de infecção fatal, 2010. URL consultato il 26 agosto 2011.

web.archive.org

MMS: Error Archiviato il 20 gennaio 2013 in Internet Archive.
Silvia Turroni . Alma Mater Studiorum . Università Di Bologna, Dott, Il microbiota intestinale - Impatto di rifaximina sul microbiota intestinale: selezione di bifidobatteri antibiotico resistenti (PDF), in Dottorato Di Ricerca in Biocatalisi Applicata E Microbiologia Industriale, 2008. URL consultato il 29 agosto 2011 (archiviato dall'url originale il 12 agosto 2011).
Hofmeister, Erik, Melinda Cumming, and Cheryl Dhein, Owner Documentation of Coprophagia in the Canine, 2001 (archiviato dall'url originale il 27 aprile 2007). Accessed November 17, 2005.
Bakken, J.S., Fecal Bacteriotherapy for recurrent Clostridium difficile associated Diarrhea (PDF), in : www.anaerobe.org, 2008. URL consultato il 27 agosto 2011 (archiviato dall'url originale il 31 maggio 2015).
Website, Rhode Island Department of Health A. Rhode Island Government, Virulent Clostridium difficile (NAP1 or ribotype 027): An emerging pathogen, 2007 (archiviato dall'url originale il 16 giugno 2011).
M.D. Thomas J. Borody e M.A. Ori Ashman, Treatment of Ulcerative Colitis Using Fecal Bacteriotherapy (PDF), in J Clin Gastroenterol, vol. 37, n. 1, 2003, pp. 42–47, PMID 1281120. URL consultato il 27 agosto 2011 (archiviato dall'url originale il 25 agosto 2011).
Linee guida della American Gastroenterological Association (PDF), su thepowerofpoop.com, American Gastroenterological Association (AGA), 2013 (archiviato dall'url originale il 16 marzo 2015).
Bacteriotherapy, \wjm-New\Faecal, Clostridium difficile – a New Non-Antibiotic Treatment (PDF) (archiviato dall'url originale il 4 settembre 2011).
Autologous Rehabilitation of Gastrointestinal Flora (ARGF) (PDF) (archiviato dall'url originale il 4 settembre 2011).